4.10.22Segment

Podiatry

Podiatric medicine and surgery practices, diabetic foot care programs, and podiatry management organizations treating foot, ankle, and lower extremity conditions.

5
Verticals

Overview

Podiatry covers podiatric medicine and surgery practices, diabetic foot-care programs, and podiatry management organizations treating foot, ankle, and lower-extremity conditions. Demand is supported by the aging population, diabetes prevalence, and the high cost of diabetic foot complications.

It is a fragmented specialty seeing emerging MSO and PE consolidation, with ancillary services (imaging, surgery, durable medical equipment) and diabetic-care programs enhancing the economics. The federal data places it in its own physician-office category.

Market snapshot

Market size
~$5.4B
Growth
~3.0%CAGR (2017–22, nominal)
Companies
~6,639 firms
Firms by employee count

95.7% of firms have fewer than 20 employees: 6,351 micro-businesses, below most mandates.

The investable universe288 firms with 20+ employees
20–99
22277%
100–499
259%
500+
4114%

~6,600 small podiatry practices (96% under 20 staff), a steady ~3%/yr aging-and-diabetes-driven specialty. A late-cycle roll-up target: PE-backed podiatry platforms are assembling the fragmented base, though only 41 firms exceed 500 employees.

NAICS 621391. U.S. Census Bureau, 2022 Statistics of U.S. Businesses; U.S. Census Bureau, 2022 Economic Census.

Business model & economics

Revenue model

Visit and procedure reimbursement plus ancillaries

Key economics

Revenue per firm
$808,376
Revenue per employee
$144,857
Employees per firm
5.5
Recurring revenue
Moderate

recurring diabetic and chronic foot care

EBITDA margin
15–25%
Capex intensity
Low

Characteristics

  • Balanced cost base: payroll is 35% of revenue, leaving room to scale margin without cutting staff
  • Moderate strategic-buyer pool: 41 firms exceed 500 employees, so a scaled asset has buyers, but not many
  • Aging and diabetes prevalence drive demand.
  • Ancillaries and diabetic-care programs enhance economics.
  • Emerging MSO/PE consolidation.

NAICS 621391. U.S. Census Bureau, 2022 Statistics of U.S. Businesses; U.S. Census Bureau, 2022 Economic Census.

Geographic concentration

AlabamaAlaskaArizonaColoradoFloridaGeorgiaIndianaKansasMaineMassachusettsMinnesotaNorth CarolinaNorth DakotaOklahomaSouth DakotaTexasWyomingMissouriWest VirginiaIllinoisNew MexicoArkansasCaliforniaDelawareDistrict of ColumbiaHawaiiIowaKentuckyMarylandMichiganMississippiMontanaNew HampshireOhioOregonTennesseeUtahVirginiaWashingtonWisconsinNebraskaSouth CarolinaIdahoNevadaVermontLouisianaRhode IslandNew JerseyPennsylvaniaConnecticutNew York

Podiatry practices concentrate in the dense Northeast corridor of New Jersey, New York, Pennsylvania, and Connecticut, tracking population age and physician density.

New JerseyNew YorkPennsylvaniaConnecticut

U.S. Census Bureau, 2022 Statistics of U.S. Businesses (firms by state), NAICS 621391. Concentration shown by location quotient.

M&A deal context

Deal activityModerate

Who’s acquiring

  • Podiatry MSO platforms
  • PE-backed consolidators
  • Multispecialty groups

What’s driving deals

  • Emerging podiatry roll-up.
  • Diabetes and aging-driven demand.
  • Ancillary-driven economics.

Verticals in this segment

Find Podiatry acquisition targets

Search Acquisera’s index for companies classified under Podiatry (4.10.22) and build a targeted deal pipeline.

Search companies